Theraclion SA (TCLIF) AI Stock Analysis

Top Page

Theraclion SA

(Other OTC:TCLIF)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Non-invasive therapeutic technologyTheraclion’s focus on non-invasive, image-guided treatment addresses procedures where avoiding surgery may be clinically valuable. A specialized technology platform in established thyroid and breast indications can support durable differentiation and continued commercialization as provider adoption develops.

Negative Factors

Persistent unprofitable operationsPersistent losses across gross, operating, and net levels show that the current revenue base does not support the cost structure. Without a sustained improvement in revenue or margins, profitability remains structurally unresolved and may continue consuming capital over the next several quarters.

Theraclion SA (TCLIF) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $39.25M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -6.8
Beta (1Y): 0.00
Revenue Growth: -11.09%
EPS Growth: 14.45%
Country: US
Employees: 36
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Devices

Theraclion SA Business Overview & Revenue Model

Company Description

Theraclion SA, established in 2004 and based in Malakoff, France, specializes in developing innovative echotherapy medical solutions. These treatments harness high-intensity focused ultrasound (HIFU) technology. Their offerings include SONOVEIN, a ro...

Theraclion SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TCLIF against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
FR:ALIKO	46Neutral	EUR 22.42M	-5.20	-22.03%	―	37.28%	7.83%
FR:ALMKT	45Neutral	EUR 18.94M	1.53	-157.72%	―	3.38%	―
FR:ALNOV	45Neutral	EUR 31.94M	-0.76	-159.70%	―	10.36%	29.41%
FR:ALMDT	43Neutral	EUR 180.85M	-3.00	271.64%	―	2.16%	-5.26%

* Healthcare Sector Average

Performance Comparison

TCLIF and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TCLIF	Theraclion SA	0.53	0.21	66.25%
FR:ALMKT	MAUNA KEA TECHNOLOGIES	0.10	-0.00	-1.02%
FR:ALNOV	Novacyt S.A.	0.44	-0.02	-4.35%
FR:ALDMS	Diagnostic Medical Systems	0.91	-0.41	-30.95%
FR:ALIKO	Ikonisys SA	1.42	-0.04	-2.74%
FR:ALMDT	Median Technologies	3.69	0.79	27.24%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Theraclion SA AI Stock Analysis